Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

May 01, 2002; Volume 30,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderson, Bradley D.

    1. You have access
      Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
  2. Andersson, Paul

    1. You have access
      Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  3. Ariyoshi, Noritaka

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534

B

  1. Baillie, Thomas A.

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  2. Blumer, Jeffrey L.

    1. You have access
      3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519
  3. Bode, W.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  4. Born, Stephanie L.

    1. You have access
      Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483
  5. Bosron, William F.

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488
  6. Buckley, Arthur R.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  7. Buckley, Donna J.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

C

  1. Caudill, Douglas

    1. You have access
      Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483
  2. Crespi, Charles

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595

D

  1. Desai, Pankaj B.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  2. Desta, Zeruesenay

    1. You have access
      Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
  3. Ding, Xinxin

    1. You have access
      Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
  4. Du, Bert N. La

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

E

  1. Edwards, Jeffrey E.

    1. You have access
      Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

F

  1. Falany, Charles N.

    1. You have access
      Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  2. Fang, Xiaojun

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  3. Fitzpatrick, Jennifer L.

    1. You have access
      Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570
  4. Fliter, Kristine L.

    1. You have access
      Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483
  5. Flockhart, David A.

    1. You have access
      Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
  6. Furuta, Shigeru

    1. You have access
      Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

G

  1. Gaedigk, Andrea

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  2. Goodwin, Bryan J.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608

H

  1. Hendrickx, J.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  2. Hosokawa, Masakiyo

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488
  3. Hsieh, Faye

    1. You have access
      Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

I

  1. Igarashi, Takashi

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  2. Ishii, Itsuko

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  3. Ishii, Mikio

    1. You have access
      Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

K

  1. Kamei, Toshio

    1. You have access
      Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494
  2. Kawabata, Yoshihiro

    1. You have access
      Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498
  3. Kitada, Mitsukazu

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  4. Kothare, Prajakti A.

    1. You have access
      Intestinal Metabolism: The Role of Enzyme Localization in Phenol Metabolite Kinetics
      Prajakti A. Kothare and Cheryl L. Zimmerman
      Drug Metabolism and Disposition May 2002, 30 (5) 586-594; DOI: https://doi.org/10.1124/dmd.30.5.586
  5. Kurimoto, Tadashi

    1. You have access
      Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

L

  1. Lavrijsen, K.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  2. Leeder, J. Steven

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  3. Leempoels, J.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  4. Le Jeune, L.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  5. Lin, Jiunn H.

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  6. Little, Joanna M.

    1. You have access
      Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531
  7. Liu, Lan

    1. You have access
      Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

M

  1. Ma, Bennett

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  2. Mannens, G. S. J.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  3. Marcucci, Kenda A.

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  4. McNamara, Patrick J.

    1. You have access
      Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
  5. Meloche, Connie A.

    1. You have access
      Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  6. Meuldermans, W.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  7. Miyazawa, Mitsuo

    1. You have access
      Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602
  8. Moore, Linda B.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  9. Morgan, Michael E.

    1. You have access
      Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479

N

  1. Nakamura, Hiroyoshi

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  2. Nakasa, Hiromitsu

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  3. Nallani, Srikanth C.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  4. Nishigaki, Ryuichiro

    1. You have access
      Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498

O

  1. Ohmori, Shigeru

    1. You have access
      Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
      Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
      Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  2. Otake, Yoko

    1. You have access
      Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576

P

  1. Pearce, Robin E.

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  2. Pearson, Paul G.

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  3. Peters, Jeffrey M.

    1. You have access
      Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570
  4. Prough, Russell A.

    1. You have access
      Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570
  5. Prueksaritanont, Thomayant

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  6. Purdon, Michael P.

    1. You have access
      Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
      Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
      Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

Q

  1. Qiu, Yue

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505

R

  1. Radominska-Pandya, Anna

    1. You have access
      Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531
  2. Rae, James M.

    1. You have access
      Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
  3. Ripp, Sharon L.

    1. You have access
      Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
      Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
      Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570

S

  1. Sane, Rucha S.

    1. You have access
      Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
      Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
      Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
  2. Sanghani, Sonal P.

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488
  3. Satoh, Tetsuo

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488
  4. Savolainen, Jouko

    1. You have access
      Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
      Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
      Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
  5. Sharma, Vyas

    1. You have access
      Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  6. Shimada, Tsutomu

    1. You have access
      Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602
  7. Shindo, Masaki

    1. You have access
      Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
      Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
      Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602
  8. Shinozaki, Yutaka

    1. You have access
      Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
      Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
      Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498
  9. Snel, C. A. W.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  10. Soukhova, Nadia V.

    1. You have access
      Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
      James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
      Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
  11. Steimel, Dorothy T.

    1. You have access
      Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
      Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
      Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  12. Su, Ting

    1. You have access
      Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
  13. Subramanian, Raju

    1. You have access
      Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
      Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
      Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  14. Swedmark, Stellan

    1. You have access
      Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
      Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
      Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  15. Swiatek, Pam

    1. You have access
      Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548

T

  1. Takenaga, Norihiro

    1. You have access
      Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494
  2. Taylor, Eve M.

    1. You have access
      Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
      Rongzi Yan and Eve M. Taylor
      Drug Metabolism and Disposition May 2002, 30 (5) 513-518; DOI: https://doi.org/10.1124/dmd.30.5.513
  3. Taylor, Palmer

    1. You have access
      Current Progress on Esterases: From Molecular Structure to Function
      Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
      Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

V

  1. van Beijsterveldt, L.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  2. Van Osselaer, N.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  3. Van Peer, A.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  4. Verhaeghe, T.

    1. You have access
      The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
      G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
      Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553

W

  1. Walle, Thomas

    1. You have access
      Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
      U. Kristina Walle and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 564-569; DOI: https://doi.org/10.1124/dmd.30.5.564
    2. You have access
      Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
      Yoko Otake, Faye Hsieh and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576
  2. Walle, U. Kristina

    1. You have access
      Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
      U. Kristina Walle and Thomas Walle
      Drug Metabolism and Disposition May 2002, 30 (5) 564-569; DOI: https://doi.org/10.1124/dmd.30.5.564
  3. Webster, Leslie T.

    1. You have access
      3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519
  4. Williams, Lisa

    1. You have access
      Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531

X

  1. Xie, Mingxing

    1. You have access
      Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541
  2. Xu, Jing

    1. You have access
      Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
      Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
      Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531
  3. Xue, Bob

    1. You have access
      Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541

Y

  1. Yan, Bingfang

    1. You have access
      Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541
  2. Yan, Maohe

    1. You have access
      3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519
  3. Yan, Rongzi

    1. You have access
      Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
      Rongzi Yan and Eve M. Taylor
      Drug Metabolism and Disposition May 2002, 30 (5) 513-518; DOI: https://doi.org/10.1124/dmd.30.5.513
  4. Yang, Dongfang

    1. You have access
      Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
      Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
      Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541
  5. Yasumori, Toshio

    1. You have access
      Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
      Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
      Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494

Z

  1. Zhang, Jianhua

    1. You have access
      Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
  2. Zhang, Qing-Yu

    1. You have access
      Expression of the Rat CYP2A3 Gene in Transgenic Mice
      Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
      Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
  3. Zimmerman, Cheryl L.

    1. You have access
      Intestinal Metabolism: The Role of Enzyme Localization in Phenol Metabolite Kinetics
      Prajakti A. Kothare and Cheryl L. Zimmerman
      Drug Metabolism and Disposition May 2002, 30 (5) 586-594; DOI: https://doi.org/10.1124/dmd.30.5.586
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 30 (5)
Drug Metabolism and Disposition
Vol. 30, Issue 5
1 May 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics